Related Experiment Videos
Clinical issues surrounding once-daily aminoglycoside dosing in children
Chad A Knoderer1, Julie A Everett, William F Buss
1Department of Pharmacy Services, James Whitcomb Riley Hospital for Children, Indianapolis, Indiana 46202, USA. cknoderer@clarian.org
Insights
Once-daily aminoglycoside antibiotic dosing shows promise in children, matching adult efficacy with potentially lower toxicity. Further pediatric research is needed to overcome barriers to adopting this simpler dosing strategy.
Area of Science:
- Pediatric Infectious Diseases
- Pharmacokinetics
- Antibiotic Stewardship
Background:
- Aminoglycoside antibiotics are crucial for treating pediatric infections.
- Current pediatric dosing (every 8-12 hours) differs from adult once-daily regimens.
- Adult studies suggest once-daily dosing is effective and safe.
Purpose of the Study:
- To evaluate the feasibility and potential benefits of once-daily aminoglycoside dosing in children.
- To address the lack of pediatric data hindering adoption of once-daily regimens.
- To explore reasons for the slow uptake of once-daily aminoglycoside dosing in pediatric hospitals.
Main Methods:
- Review of existing adult and pediatric studies on aminoglycoside dosing.
- Analysis of pharmacokinetic data in children, including clearance rates.
- Assessment of safety and efficacy data for once-daily versus traditional dosing.
Main Results:
- Adult studies demonstrate equivalent efficacy and reduced toxicity with once-daily aminoglycoside regimens.
- Pediatric populations exhibit rapid aminoglycoside clearance, complicating once-daily dosing.
- Limited pediatric clinical and efficacy data, alongside safety concerns, impede widespread adoption.
Conclusions:
- Once-daily aminoglycoside dosing presents a potentially simpler and safer alternative for pediatric patients.
- Further pediatric-specific research is essential to establish safety, efficacy, and optimal dosing intervals.
- Overcoming barriers like rapid clearance and limited data is key to implementing once-daily aminoglycoside therapy in children.
Abstract:
Aminoglycoside antibiotics are first-line treatment for many infectious diseases in the pediatric population and are effective in adults. The traditional dosing interval in children is every 8-12 hours. Studies in adults reported equivalent efficacy and equal or less toxicity with once-daily regimens. Despite many studies in the adult population, this approach has yet to become standard practice in most pediatric hospitals. Reasons for lack of acceptance of this strategy in children include rapid aminoglycoside clearance, unknown duration of postantibiotic effect, safety concerns, and limited clinical and efficacy data.